Skip to main content
SpringerLink
Log in

Epidemiology of AMD

  • Chapter
  • First Online:
Book cover Age-related Macular Degeneration

Abstract

This chapter will provide an update on the epidemiology of age-related macular degeneration (AMD) as it has developed during the past few years, since the last edition in 2003. We shall review the current epidemiological literature, and discuss diagnosis, frequency, genetic and environmental factors, and the possible interaction between them.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bird AC, Bressler NM, Bressler SB et al (1995) An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol 39(5):367–374

    Article  PubMed  CAS  Google Scholar 

  2. Klein R, Davis MD, Magli YL, Segal P, Klein BE, Hubbard L (1991) The Wisconsin age-related maculopathy grading system. Ophthalmology 98(7):1128–1134

    PubMed  CAS  Google Scholar 

  3. Sho K, Takahashi K, Yamada H et al (2003) Polypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristics. Arch Ophthalmol 121(10):1392–1396

    Article  PubMed  Google Scholar 

  4. Kwok AK, Lai TY, Chan CW, Neoh EL, Lam DS (2002) Polypoidal choroidal vasculopathy in Chinese patients. Br J Ophthalmol 86(8):892–897

    Article  PubMed  CAS  Google Scholar 

  5. Maruko I, Iida T, Saito M, Nagayama D, Saito K (2007) Clinical characteristics of exudative age-related macular degeneration in Japanese patients. Am J Ophthalmol 144(1):15–22

    Article  PubMed  Google Scholar 

  6. Oshima Y, Ishibashi T, Murata T, Tahara Y, Kiyohara Y, Kubota T (2001) Prevalence of age related maculopathy in a representative Japanese population: the Hisayama study. Br J Ophthalmol 85(10):1153–1157

    Article  PubMed  CAS  Google Scholar 

  7. Nirmalan PK, Katz J, Robin AL et al (2004) Prevalence of vitreoretinal disorders in a rural population of southern India: the Aravind Comprehensive Eye Study. Arch Ophthalmol 122(4):581–586

    Article  PubMed  Google Scholar 

  8. Gupta SK, Murthy GV, Morrison N et al (2007) Prevalence of early and late age-related macular degeneration in a rural population in northern India: the INDEYE feasibility study. Invest Ophthalmol Vis Sci 48(3):1007–1011

    Article  PubMed  Google Scholar 

  9. Cheng Y, Chen KJ, Wang CJ, Chan SH, Chang WC, Chen JH (2005) Secular trends in coronary heart disease mortality, hospitalization rates, and major cardiovascular risk factors in Taiwan, 1971–2001. Int J Cardiol 100(1):47–52

    Article  PubMed  Google Scholar 

  10. Shetty P, Schmidhuber J (2006) Introductory lecture the epidemiology and determinants of obesity in developed and developing countries. Int J Vitam Nutr Res 76(4):157–162

    Article  PubMed  CAS  Google Scholar 

  11. Eapen D, Kalra GL, Merchant N, Arora A, Khan BV (2009) Metabolic syndrome and cardiovascular disease in South Asians. Vasc Health Risk Manag 5:731–743

    PubMed  Google Scholar 

  12. Misra A, Khurana L (2009) The metabolic syndrome in South Asians: epidemiology, determinants, and prevention. Metab Syndr Relat Disord 7(6):497–514

    Article  PubMed  Google Scholar 

  13. Jampol LM, Tielsch J (1992) Race, macular degeneration, and the Macular Photocoagulation Study. Arch Ophthalmol 110(12):1699–1700

    Article  PubMed  CAS  Google Scholar 

  14. Pieramici DJ, Bressler NM, Bressler SB, Schachat AP (1994) Choroidal neovascularization in black patients. Arch Ophthalmol 112(8):1043–1046

    Article  PubMed  CAS  Google Scholar 

  15. Smith W, Assink J, Klein R et al (2001) Risk factors for age-related macular degeneration: pooled findings from three continents. Ophthalmology 108(4):697–704

    Article  PubMed  CAS  Google Scholar 

  16. Leske MC, Wu SY, Hennis A et al (2006) Nine-year incidence of age-related macular degeneration in the Barbados Eye Studies. Ophthalmology 113(1):29–35

    Article  PubMed  Google Scholar 

  17. Varma R, Foong AW, Lai MY, Choudhury F, Klein R, Azen SP (2010) Four-year incidence and progression of age-related macular degeneration: the Los Angeles Latino Eye Study. Am J Ophthalmol 149(5):741–751

    Article  PubMed  Google Scholar 

  18. Yasuda M, Kiyohara Y, Hata Y et al (2009) Nine-year incidence and risk factors for age-related macular degeneration in a defined Japanese population the Hisayama study. Ophthalmology 116(11):2135–2140

    Article  PubMed  Google Scholar 

  19. Klein R, Klein BE, Knudtson MD, Meuer SM, Swift M, Gangnon RE (2007) Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study. Ophthalmology 114(2):253–262

    Article  PubMed  Google Scholar 

  20. Wang JJ, Rochtchina E, Lee AJ et al (2007) Ten-year incidence and progression of age-related maculopathy: the blue Mountains Eye Study. Ophthalmology 114(1):92–98

    Article  PubMed  Google Scholar 

  21. Buch H, Nielsen NV, Vinding T, Jensen GB, Prause JU, la Cour M (2005) 14-year incidence, progression, and visual morbidity of age-related maculopathy: the Copenhagen City Eye Study. Ophthalmology 112(5):787–798

    Article  PubMed  Google Scholar 

  22. Jonasson F, Arnarsson A, Peto T, Sasaki H, Sasaki K, Bird AC (2005) 5-year incidence of age-related maculopathy in the Reykjavik Eye Study. Ophthalmology 112(1):132–138

    Article  PubMed  Google Scholar 

  23. Delcourt C, Lacroux A, Carriere I (2005) The three-year incidence of age-related macular degeneration: the “Pathologies Oculaires Liees a l’Age” (POLA) prospective study. Am J Ophthalmol 140(5):924–926

    Article  PubMed  Google Scholar 

  24. Mukesh BN, Dimitrov PN, Leikin S et al (2004) Five-year incidence of age-related maculopathy: the Visual Impairment Project. Ophthalmology 111(6):1176–1182

    Article  PubMed  Google Scholar 

  25. van Leeuwen R, Klaver CC, Vingerling JR, Hofman A, de Jong PT (2003) The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam study. Arch Ophthalmol 121(4):519–526

    Article  PubMed  Google Scholar 

  26. Klein R, Klein BE, Tomany SC, Meuer SM, Huang GH (2002) Ten-year incidence and progression of age-related maculopathy: the Beaver Dam eye study. Ophthalmology 109(10):1767–1779

    Article  PubMed  Google Scholar 

  27. Mitchell P, Wang JJ, Foran S, Smith W (2002) Five-year incidence of age-related maculopathy lesions: the Blue Mountains Eye Study. Ophthalmology 109(6):1092–1097

    Article  PubMed  Google Scholar 

  28. Klaver CC, Assink JJ, van Leeuwen R et al (2001) Incidence and progression rates of age-related maculopathy: the Rotterdam Study. Invest Ophthalmol Vis Sci 42(10):2237–2241

    PubMed  CAS  Google Scholar 

  29. Macular Photocoagulation Study Group (1997) Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration. Arch Ophthalmol 115(6):741–747

    Article  Google Scholar 

  30. Davis MD, Gangnon RE, Lee LY et al (2005) The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17. Arch Ophthalmol 123(11):1484–1498

    Article  PubMed  Google Scholar 

  31. Ferris FL, Davis MD, Clemons TE et al (2005) A simplified severity scale for age-related macular degeneration: AREDS Report No. 18. Arch Ophthalmol 123(11):1570–1574

    Article  PubMed  Google Scholar 

  32. Bressler SB, Munoz B, Solomon SD, West SK (2008) Racial differences in the prevalence of age-related macular degeneration: the Salisbury Eye Evaluation (SEE) Project. Arch Ophthalmol 126(2):241–245

    Article  PubMed  Google Scholar 

  33. Klein R, Klein BE, Jensen SC, Meuer SM (1997) The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 104(1):7–21

    PubMed  CAS  Google Scholar 

  34. Age-Related Eye Disease Study Research Group (2001) A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 119(10):1417–1436

    Article  Google Scholar 

  35. Holz FG, Wolfensberger TJ, Piguet B et al (1994) Bilateral macular drusen in age-related macular degeneration. Prognosis and risk factors. Ophthalmology 101(9):1522–1528

    PubMed  CAS  Google Scholar 

  36. Holz FG, Wolfensberger TJ, Piguet B, Minassian D, Bird AC (1994) Macular drusen. Changes in the retinal pigment epithelium and angiographic characteristics as prognostic markers. Ophthalmologe 91(6):735–740

    PubMed  CAS  Google Scholar 

  37. Mitchell P, Foran S (2005) Age-Related Eye Disease Study severity scale and simplified severity scale for age-related macular degeneration. Arch Ophthalmol 123(11):1598–1599

    Article  PubMed  Google Scholar 

  38. Wang JJ, Foran S, Smith W, Mitchell P (2003) Risk of age-related macular degeneration in eyes with macular drusen or hyperpigmentation: the Blue Mountains Eye Study cohort. Arch Ophthalmol 121(5):658–663

    Article  PubMed  Google Scholar 

  39. Macular Photocoagulation Study Group (1993) Five-year follow-up of fellow eyes of patients with age-related macular degeneration and unilateral extrafoveal choroidal neovascularization. Arch Ophthalmol 111(9):1189–1199

    Article  Google Scholar 

  40. Baun O, Vinding T, Krogh E (1993) Natural course in fellow eyes of patients with unilateral age-related exudative maculopathy. A fluorescein angiographic 4-year follow-up of 45 patients. Acta Ophthalmol (Copenh) 71(3):398–401

    Article  CAS  Google Scholar 

  41. Sarraf D, Gin T, Yu F, Brannon A, Owens SL, Bird AC (1999) Long-term drusen study. Retina 19(6):513–519

    Article  PubMed  CAS  Google Scholar 

  42. Sunness JS (2006) Choroidal neovascularisation and atrophy. Br J Ophthalmol 90(4):398–399

    Article  PubMed  CAS  Google Scholar 

  43. Sunness JS, Gonzalez-Baron J, Bressler NM, Hawkins B, Applegate CA (1999) The development of choroidal neovascularization in eyes with the geographic atrophy form of age-related macular degeneration. Ophthalmology 106(5):910–919

    Article  PubMed  CAS  Google Scholar 

  44. Sunness JS, Margalit E, Srikumaran D et al (2007) The long-term natural history of geographic atrophy from age-related macular degeneration: enlargement of atrophy and implications for interventional clinical trials. Ophthalmology 114(2):271–277

    Article  PubMed  Google Scholar 

  45. Swaroop A, Branham KE, Chen W, Abecasis G (2007) Genetic susceptibility to age-related macular degeneration: a paradigm for dissecting complex disease traits. Hum Mol Genet 16(2):R174–R182

    Article  PubMed  CAS  Google Scholar 

  46. Conley YP, Jakobsdottir J, Mah T et al (2006) CFH, ELOVL4, PLEKHA1 and LOC387715 genes and susceptibility to age-related maculopathy: AREDS and CHS cohorts and meta-analyses. Hum Mol Genet 15(21):3206–3218

    Article  PubMed  CAS  Google Scholar 

  47. Thakkinstian A, Bowe S, McEvoy M, Smith W, Attia J (2006) Association between apolipoprotein E polymorphisms and age-related macular degeneration: a HuGE review and meta-analysis. Am J Epidemiol 164(9):813–822

    Article  PubMed  Google Scholar 

  48. Yates JR, Sepp T, Matharu BK et al (2007) Complement C3 variant and the risk of age-related macular degeneration. N Engl J Med 357(6):553–561

    Article  PubMed  CAS  Google Scholar 

  49. Gold B, Merriam JE, Zernant J et al (2006) Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet 38(4):458–462

    Article  PubMed  CAS  Google Scholar 

  50. Abecasis GR, Yashar BM, Zhao Y et al (2004) Age-related macular degeneration: a high-resolution genome scan for susceptibility loci in a population enriched for late-stage disease. Am J Hum Genet 74(3):482–494

    Article  PubMed  CAS  Google Scholar 

  51. Klein ML, Schultz DW, Edwards A et al (1998) Age-related macular degeneration. Clinical features in a large family and linkage to chromosome 1q. Arch Ophthalmol 116(8):1082–1088

    PubMed  CAS  Google Scholar 

  52. Majewski J, Schultz DW, Weleber RG et al (2003) Age-related macular degeneration – a genome scan in extended families. Am J Hum Genet 73(3):540–550

    Article  PubMed  CAS  Google Scholar 

  53. Weeks DE, Conley YP, Tsai HJ et al (2004) Age-related maculopathy: a genomewide scan with continued evidence of susceptibility loci within the 1q31, 10q26, and 17q25 regions. Am J Hum Genet 75(2):174–189

    Article  PubMed  CAS  Google Scholar 

  54. Weber JL, Broman KW (2001) Genotyping for human whole-genome scans: past, present, and future. Adv Genet 42:77–96

    Article  PubMed  CAS  Google Scholar 

  55. Seddon JM, Santangelo SL, Book K, Chong S, Cote J (2003) A genomewide scan for age-related macular degeneration provides evidence for linkage to several chromosomal regions. Am J Hum Genet 73(4):780–790

    Article  PubMed  CAS  Google Scholar 

  56. Iyengar SK, Song D, Klein BE et al (2004) Dissection of genomewide-scan data in extended families reveals a major locus and oligogenic susceptibility for age-related macular degeneration. Am J Hum Genet 74(1):20–39

    Article  PubMed  CAS  Google Scholar 

  57. Klein RJ, Zeiss C, Chew EY et al (2005) Complement factor H polymorphism in age-related macular degeneration. Science 308(5720):385–389

    Article  PubMed  CAS  Google Scholar 

  58. Edwards AO, Ritter R III, Abel KJ, Manning A, Panhuysen C, Farrer LA (2005) Complement factor H polymorphism and age-related macular degeneration. Science 308(5720):421–424

    Article  PubMed  CAS  Google Scholar 

  59. Haines JL, Hauser MA, Schmidt S et al (2005) Complement factor H variant increases the risk of age-related macular degeneration. Science 308(5720):419–421

    Article  PubMed  CAS  Google Scholar 

  60. Souied EH, Leveziel N, Richard F et al (2005) Y402H complement factor H polymorphism associated with exudative age-related macular degeneration in the French population. Mol Vis 11:1135–1140

    PubMed  CAS  Google Scholar 

  61. Magnusson KP, Duan S, Sigurdsson H et al (2006) CFH Y402H confers similar risk of soft drusen and both forms of advanced AMD. PLoS Med 3(1):e5

    Article  PubMed  CAS  Google Scholar 

  62. Rivera A, Fisher SA, Fritsche LG et al (2005) Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Hum Mol Genet 14(21):3227–3236

    Article  PubMed  CAS  Google Scholar 

  63. Zareparsi S, Branham KE, Li M et al (2005) Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration. Am J Hum Genet 77(1):149–153

    Article  PubMed  CAS  Google Scholar 

  64. Hageman GS, Anderson DH, Johnson LV et al (2005) A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci USA 102(20):7227–7232

    Article  PubMed  CAS  Google Scholar 

  65. Sepp T, Khan JC, Thurlby DA et al (2006) Complement ­factor H variant Y402H is a major risk determinant for ­geographic atrophy and choroidal neovascularization in smokers and nonsmokers. Invest Ophthalmol Vis Sci 47(2):536–540

    Article  PubMed  Google Scholar 

  66. Despriet DD, Klaver CC, Witteman JC et al (2006) Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration. JAMA 296(3):301–309

    Article  PubMed  Google Scholar 

  67. Fisher SA, Rivera A, Fritsche LG, Babadjanova G, Petrov S, Weber BH (2007) Assessment of the contribution of CFH and chromosome 10q26 AMD susceptibility loci in a Russian population isolate. Br J Ophthalmol 91(5):576–578

    Article  PubMed  Google Scholar 

  68. Schaumberg DA, Christen WG, Kozlowski P, Miller DT, Ridker PM, Zee RY (2006) A prospective assessment of the Y402H variant in complement factor H, genetic variants in C-reactive protein, and risk of age-related macular degeneration. Invest Ophthalmol Vis Sci 47(6):2336–2340

    Article  PubMed  Google Scholar 

  69. Brantley MA Jr, Fang AM, King JM, Tewari A, Kymes SM, Shiels A (2007) Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to intravitreal bevacizumab. Ophthalmology 114(12):2168–2173

    Article  PubMed  Google Scholar 

  70. Seitsonen S, Lemmela S, Holopainen J et al (2006) Analysis of variants in the complement factor H, the elongation of very long chain fatty acids-like 4 and the hemicentin 1 genes of age-related macular degeneration in the Finnish population. Mol Vis 12:796–801

    PubMed  CAS  Google Scholar 

  71. Baird PN, Islam FM, Richardson AJ, Cain M, Hunt N, Guymer R (2006) Analysis of the Y402H variant of the complement factor H gene in age-related macular degeneration. Invest Ophthalmol Vis Sci 47(10):4194–4198

    Article  PubMed  Google Scholar 

  72. Mori K, Gehlbach PL, Kabasawa S et al (2007) Coding and noncoding variants in the CFH gene and cigarette smoking influence the risk of age-related macular degeneration in a Japanese population. Invest Ophthalmol Vis Sci 48(11):5315–5319

    Article  PubMed  Google Scholar 

  73. Seddon JM, George S, Rosner B, Klein ML (2006) CFH gene variant, Y402H, and smoking, body mass index, environmental associations with advanced age-related macular degeneration. Hum Hered 61(3):157–165

    Article  PubMed  CAS  Google Scholar 

  74. Losonczy G, Fekete A, Voko Z et al (2011) Analysis of complement factor H Y402H, LOC387715, HTRA1 polymorphisms and ApoE alleles with susceptibility to age-related macular degeneration in Hungarian patients. Acta Ophthalmol 89(3):255–262

    Article  PubMed  CAS  Google Scholar 

  75. Lau LI, Chen SJ, Cheng CY et al (2006) Association of the Y402H polymorphism in complement factor H gene and neovascular age-related macular degeneration in Chinese patients. Invest Ophthalmol Vis Sci 47(8):3242–3246

    Article  PubMed  Google Scholar 

  76. Ng TK, Chen LJ, Liu DT et al (2008) Multiple gene polymorphisms in the complement factor h gene are associated with exudative age-related macular degeneration in Chinese. Invest Ophthalmol Vis Sci 49(8):3312–3317

    Article  PubMed  Google Scholar 

  77. Chen LJ, Liu DT, Tam PO et al (2006) Association of complement factor H polymorphisms with exudative age-related macular degeneration. Mol Vis 12:1536–1542

    PubMed  CAS  Google Scholar 

  78. DeAngelis MM, Ji F, Kim IK et al (2007) Cigarette smoking, CFH, APOE, ELOVL4, and risk of neovascular age-related macular degeneration. Arch Ophthalmol 125(1):49–54

    Article  PubMed  CAS  Google Scholar 

  79. Pulido JS, Peterson LM, Mutapcic L, Bryant S, Highsmith WE (2007) LOC387715/HTRA1 and complement factor H variants in patients with age-related macular degeneration seen at the mayo clinic. Ophthalmic Genet 28(4):203–207

    Article  PubMed  CAS  Google Scholar 

  80. Weger M, Renner W, Steinbrugger I et al (2007) Association of the HTRA1-625G>A promoter gene polymorphism with exudative age-related macular degeneration in a Central European population. Mol Vis 13:1274–1279

    PubMed  CAS  Google Scholar 

  81. Wegscheider BJ, Weger M, Renner W et al (2007) Association of complement factor H Y402H gene polymorphism with different subtypes of exudative age-related macular degeneration. Ophthalmology 114(4):738–742

    Article  PubMed  Google Scholar 

  82. Chu J, Zhou CC, Lu N, Zhang X, Dong FT (2008) Genetic variants in three genes and smoking show strong associations with susceptibility to exudative age-related macular degeneration in a Chinese population. Chin Med J (Engl) 121(24):2525–2533

    Google Scholar 

  83. Droz I, Mantel I, Ambresin A, Faouzi M, Schorderet DF, Munier FL (2008) Genotype-phenotype correlation of age-related macular degeneration: influence of complement factor H polymorphism. Br J Ophthalmol 92(4):513–517

    Article  PubMed  CAS  Google Scholar 

  84. Xu Y, Guan N, Xu J et al (2008) Association of CFH, LOC387715, and HTRA1 polymorphisms with exudative age-related macular degeneration in a northern Chinese population. Mol Vis 14:1373–1381

    PubMed  CAS  Google Scholar 

  85. Chowers I, Cohen Y, Goldenberg-Cohen N et al (2008) Association of complement factor H Y402H polymorphism with phenotype of neovascular age related macular degeneration in Israel. Mol Vis 14:1829–1834

    PubMed  CAS  Google Scholar 

  86. Liu X, Zhao P, Tang S et al (2010) Association Study of Complement Factor H, C2, Cfb, and C3 and Age-related macular degeneration in a Han Chinese population. Retina 30:1177–1184

    Article  PubMed  Google Scholar 

  87. Kim IK, Ji F, Morrison MA et al (2008) Comprehensive analysis of CRP, CFH Y402H and environmental risk factors on risk of neovascular age-related macular degeneration. Mol Vis 14:1487–1495

    PubMed  CAS  Google Scholar 

  88. Ricci F, Zampatti S, D’Abbruzzi F et al (2009) Typing of ARMS2 and CFH in age-related macular degeneration: case-control study and assessment of frequency in the Italian population. Arch Ophthalmol 127(10):1368–1372

    Article  PubMed  CAS  Google Scholar 

  89. Cui L, Zhou H, Yu J et al (2010) Noncoding variant in the complement factor H gene and risk of exudative age-related macular degeneration in a Chinese population. Invest Ophthalmol Vis Sci 51(2):1116–1120

    Article  PubMed  Google Scholar 

  90. Fuse N, Miyazawa A, Mengkegale M et al (2006) Polymorphisms in Complement Factor H and Hemicentin-1 genes in a Japanese population with dry-type age-related macular degeneration. Am J Ophthalmol 142(6):1074–1076

    Article  PubMed  CAS  Google Scholar 

  91. Tedeschi-Blok N, Buckley J, Varma R, Triche TJ, Hinton DR (2007) Population-based study of early age-related macular degeneration: role of the complement factor H Y402H polymorphism in bilateral but not unilateral disease. Ophthalmology 114(1):99–103

    Article  PubMed  Google Scholar 

  92. Ziskind A, Bardien S, van der Merwe L, Webster AR (2008) The frequency of the H402 allele of CFH and its involvement with age-related maculopathy in an aged Black African Xhosa population. Ophthalmic Genet 29(3):117–119

    Article  PubMed  Google Scholar 

  93. Gao Y, Li Y, Xu L, Zhang HT, Jonas JB, Sun BC (2010) Complement factor H polymorphism in age-related maculopathy in the Chinese population: the Beijing Eye Study. Retina 30(3):443–446

    Article  PubMed  Google Scholar 

  94. Rodriguez de Cordoba S, Esparza-Gordillo J, Goicoechea de Jorge E, Lopez-Trascasa M, Sanchez-Corral P (2004) The human complement factor H: functional roles, genetic variations and disease associations. Mol Immunol 41(4):355–367

    Article  PubMed  CAS  Google Scholar 

  95. Skerka C, Lauer N, Weinberger AA et al (2007) Defective complement control of factor H (Y402H) and FHL-1 in age-related macular degeneration. Mol Immunol 44(13):3398–3406

    Article  PubMed  CAS  Google Scholar 

  96. Laine M, Jarva H, Seitsonen S et al (2007) Y402H polymorphism of complement factor H affects binding affinity to C-reactive protein. J Immunol 178(6):3831–3836

    PubMed  CAS  Google Scholar 

  97. Johnson PT, Betts KE, Radeke MJ, Hageman GS, Anderson DH, Johnson LV (2006) Individuals homozygous for the age-related macular degeneration risk-conferring variant of complement factor H have elevated levels of CRP in the choroid. Proc Natl Acad Sci USA 103(46):17456–17461

    Article  PubMed  CAS  Google Scholar 

  98. Johnson LV, Leitner WP, Staples MK, Anderson DH (2001) Complement activation and inflammatory processes in Drusen formation and age related macular degeneration. Exp Eye Res 73(6):887–896

    Article  PubMed  CAS  Google Scholar 

  99. Schmidt S, Hauser MA, Scott WK et al (2006) Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration. Am J Hum Genet 78(5):852–864

    Article  PubMed  CAS  Google Scholar 

  100. Thakkinstian A, Han P, McEvoy M et al (2006) Systematic review and meta-analysis of the association between complement factor H Y402H polymorphisms and age-related macular degeneration. Hum Mol Genet 15(18):2784–2790

    Article  PubMed  CAS  Google Scholar 

  101. Brantley MA Jr, Edelstein SL, King JM, Apte RS, Kymes SM, Shiels A (2007) Clinical phenotypes associated with the complement factor H Y402H variant in age-related macular degeneration. Am J Ophthalmol 144(3):404–408

    Article  PubMed  CAS  Google Scholar 

  102. Simonelli F, Frisso G, Testa F et al (2006) Polymorphism p.402Y  >  H in the complement factor H protein is a risk factor for age related macular degeneration in an Italian population. Br J Ophthalmol 90(9):1142–1145

    Article  PubMed  CAS  Google Scholar 

  103. Nonyane BA, Nitsch D, Whittaker JC et al (2010) An ecological correlation study of late age-related macular degeneration and the complement factor H Y402H polymorphism. Invest Ophthalmol Vis Sci 51(5):2393–2402

    Article  PubMed  Google Scholar 

  104. Li M, Atmaca-Sonmez P, Othman M et al (2006) CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degeneration. Nat Genet 38(9):1049–1054

    Article  PubMed  CAS  Google Scholar 

  105. Maller J, George S, Purcell S et al (2006) Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration. Nat Genet 38(9):1055–1059

    Article  PubMed  CAS  Google Scholar 

  106. Hughes AE, Orr N, Esfandiary H, Diaz-Torres M, Goodship T, Chakravarthy U (2006) A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration. Nat Genet 38(10):1173–1177

    Article  PubMed  CAS  Google Scholar 

  107. Spencer KL, Hauser MA, Olson LM et al (2008) Deletion of CFHR3 and CFHR1 genes in age-related macular degeneration. Hum Mol Genet 17(7):971–977

    Article  PubMed  CAS  Google Scholar 

  108. Cann HM, de Toma C, Cazes L et al (2002) A human genome diversity cell line panel. Science 296(5566):261–262

    Article  PubMed  CAS  Google Scholar 

  109. Richardson AJ, Islam FM, Guymer RH, Baird PN (2009) Analysis of rare variants in the complement component 2 (C2) and factor B (BF) genes refine association for age-related macular degeneration (AMD). Invest Ophthalmol Vis Sci 50(2):540–543

    Article  PubMed  Google Scholar 

  110. Francis PJ, Hamon SC, Ott J, Weleber RG, Klein ML (2009) Polymorphisms in C2, CFB and C3 are associated with progression to advanced age related macular degeneration associated with visual loss. J Med Genet 46(5):300–307

    Article  PubMed  CAS  Google Scholar 

  111. Spencer KL, Hauser MA, Olson LM et al (2007) Protective effect of complement factor B and complement component 2 variants in age-related macular degeneration. Hum Mol Genet 16(16):1986–1992

    Article  PubMed  CAS  Google Scholar 

  112. Kaur I, Katta S, Reddy RK et al (2010) The involvement of complement factor B and complement component C2 in an Indian cohort with age-related macular degeneration. Invest Ophthalmol Vis Sci 51(1):59–63

    Article  PubMed  Google Scholar 

  113. McKay GJ, Silvestri G, Patterson CC, Hogg RE, Chakravarthy U, Hughes AE (2009) Further assessment of the complement component 2 and factor B region associated with age-related macular degeneration. Invest Ophthalmol Vis Sci 50(2):533–539

    Article  PubMed  Google Scholar 

  114. Jakobsdottir J, Conley YP, Weeks DE, Ferrell RE, Gorin MB (2008) C2 and CFB genes in age-related maculopathy and joint action with CFH and LOC387715 genes. PLoS One 3(5):e2199

    Article  PubMed  CAS  Google Scholar 

  115. Montes T, Tortajada A, Morgan BP, Rodriguez de Cordoba S, Harris CL (2009) Functional basis of protection against age-related macular degeneration conferred by a common polymorphism in complement factor B. Proc Natl Acad Sci USA 106(11):4366–4371

    Article  PubMed  CAS  Google Scholar 

  116. Lokki ML, Koskimies SA (1991) Allelic differences in hemolytic activity and protein concentration of BF molecules are found in association with particular HLA haplotypes. Immunogenetics 34(4):242–246

    Article  PubMed  CAS  Google Scholar 

  117. Crabb JW, Miyagi M, Gu X et al (2002) Drusen prote­ome analysis: an approach to the etiology of age-related macular degeneration. Proc Natl Acad Sci USA 99(23):14682–14687

    Article  PubMed  CAS  Google Scholar 

  118. Mullins RF, Russell SR, Anderson DH, Hageman GS (2000) Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J 14(7):835–846

    PubMed  CAS  Google Scholar 

  119. Janssen BJ, Christodoulidou A, McCarthy A, Lambris JD, Gros P (2006) Structure of C3b reveals conformational changes that underlie complement activity. Nature 444(7116):213–216

    Article  PubMed  CAS  Google Scholar 

  120. Nishida N, Walz T, Springer TA (2006) Structural transitions of complement component C3 and its activation products. Proc Natl Acad Sci USA 103(52):19737–19742

    Article  PubMed  CAS  Google Scholar 

  121. Sahu A, Lambris JD (2001) Structure and biology of complement protein C3, a connecting link between innate and acquired immunity. Immunol Rev 180:35–48

    Article  PubMed  CAS  Google Scholar 

  122. Hageman GS, Luthert PJ, Victor Chong NH, Johnson LV, Anderson DH, Mullins RF (2001) An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch’s membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res 20(6):705–732

    Article  PubMed  CAS  Google Scholar 

  123. Nozaki M, Raisler BJ, Sakurai E et al (2006) Drusen complement components C3a and C5a promote choroidal neovascularization. Proc Natl Acad Sci USA 103(7):2328–2333

    Article  PubMed  CAS  Google Scholar 

  124. Maller JB, Fagerness JA, Reynolds RC, Neale BM, Daly MJ, Seddon JM (2007) Variation in complement factor 3 is associated with risk of age-related macular degeneration. Nat Genet 39(10):1200–1201

    Article  PubMed  CAS  Google Scholar 

  125. Spencer KL, Olson LM, Anderson BM et al (2008) C3 R102G polymorphism increases risk of age-related macular degeneration. Hum Mol Genet 17(12):1821–1824

    Article  PubMed  CAS  Google Scholar 

  126. Edwards AO, Fridley BL, James KM, Sharma AK, Cunningham JM, Tosakulwong N (2008) Evaluation of clustering and genotype distribution for replication in genome wide association studies: the age-related eye disease study. PLoS One 3(11):e3813

    Article  PubMed  CAS  Google Scholar 

  127. Despriet DD, van Duijn CM, Oostra BA et al (2009) Complement component C3 and risk of age-related macular degeneration. Ophthalmology 116(3):474–480 e472

    Article  PubMed  Google Scholar 

  128. Park KH, Fridley BL, Ryu E, Tosakulwong N, Edwards AO (2009) Complement component 3 (C3) haplotypes and risk of advanced age-related macular degeneration. Invest Ophthalmol Vis Sci 50(7):3386–3393

    Article  PubMed  Google Scholar 

  129. Scholl HP, Fleckenstein M, Fritsche LG et al (2009) CFH, C3 and ARMS2 are significant risk loci for susceptibility but not for disease progression of geographic atrophy due to AMD. PLoS One 4(10):e7418

    Article  PubMed  CAS  Google Scholar 

  130. McKay GJ, Dasari S, Patterson CC, Chakravarthy U, Silvestri G (2010) Complement component 3: an assessment of association with AMD and analysis of gene-gene and gene-environment interactions in a Northern Irish cohort. Mol Vis 16:194–199

    PubMed  CAS  Google Scholar 

  131. Bergeron-Sawitzke J, Gold B, Olsh A et al (2009) Multilocus analysis of age-related macular degeneration. Eur J Hum Genet 17(9):1190–1199

    Article  PubMed  CAS  Google Scholar 

  132. Pei XT, Li XX, Bao YZ et al (2009) Association of c3 gene polymorphisms with neovascular age-related macular degeneration in a Chinese population. Curr Eye Res 34(8):615–622

    Article  PubMed  CAS  Google Scholar 

  133. Fagerness JA, Maller JB, Neale BM, Reynolds RC, Daly MJ, Seddon JM (2009) Variation near complement factor I is associated with risk of advanced AMD. Eur J Hum Genet 17(1):100–104

    Article  PubMed  CAS  Google Scholar 

  134. Wang J, Ohno-Matsui K, Yoshida T et al (2008) Altered function of factor I caused by amyloid beta: implication for pathogenesis of age-related macular degeneration from Drusen. J Immunol 181(1):712–720

    PubMed  CAS  Google Scholar 

  135. Chen W, Stambolian D, Edwards AO et al (2010) Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration. Proc Natl Acad Sci USA 107(16):7401–7406

    Article  PubMed  CAS  Google Scholar 

  136. Kondo N, Bessho H, Honda S, Negi A (2010) Additional evidence to support the role of a common variant near the complement factor I gene in susceptibility to age-related macular degeneration. Eur J Hum Genet 18(6):634–635

    Article  PubMed  Google Scholar 

  137. Ennis S, Gibson J, Cree AJ, Collins A, Lotery AJ (2010) Support for the involvement of complement factor I in age-related macular degeneration. Eur J Hum Genet 18(1):15–16

    Article  PubMed  CAS  Google Scholar 

  138. Kenealy SJ, Schmidt S, Agarwal A et al (2004) Linkage analysis for age-related macular degeneration supports a gene on chromosome 10q26. Mol Vis 10:57–61

    PubMed  CAS  Google Scholar 

  139. Yang Z, Camp NJ, Sun H et al (2006) A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration. Science 314(5801):992–993

    Article  PubMed  CAS  Google Scholar 

  140. Dewan A, Liu M, Hartman S et al (2006) HTRA1 promoter polymorphism in wet age-related macular degeneration. Science 314(5801):989–992

    Article  PubMed  CAS  Google Scholar 

  141. Fisher SA, Abecasis GR, Yashar BM et al (2005) Meta-analysis of genome scans of age-related macular degeneration. Hum Mol Genet 14(15):2257–2264

    Article  PubMed  CAS  Google Scholar 

  142. Jakobsdottir J, Conley YP, Weeks DE, Mah TS, Ferrell RE, Gorin MB (2005) Susceptibility genes for age-related maculopathy on chromosome 10q26. Am J Hum Genet 77(3):389–407

    Article  PubMed  CAS  Google Scholar 

  143. Kanda A, Chen W, Othman M et al (2007) A variant of mitochondrial protein LOC387715/ARMS2, not HTRA1, is strongly associated with age-related macular degeneration. Proc Natl Acad Sci USA 104(41):16227–16232

    Article  PubMed  CAS  Google Scholar 

  144. Fritsche LG, Loenhardt T, Janssen A et al (2008) Age-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNA. Nat Genet 40(7):892–896

    Article  PubMed  CAS  Google Scholar 

  145. Gibbs D, Yang Z, Constantine R et al (2008) Further mapping of 10q26 supports strong association of HTRA1 polymorphisms with age-related macular degeneration. Vision Res 48(5):685–689

    Article  PubMed  CAS  Google Scholar 

  146. Deangelis MM, Ji F, Adams S et al (2008) Alleles in the HtrA serine peptidase 1 gene alter the risk of neovascular age-related macular degeneration. Ophthalmology 115(7):1209–1215 e1207

    Article  PubMed  Google Scholar 

  147. Hughes AE, Orr N, Patterson C et al (2007) Neovascular age-related macular degeneration risk based on CFH, LOC387715/HTRA1, and smoking. PLoS Med 4(12):e355

    Article  PubMed  CAS  Google Scholar 

  148. Seddon JM, Francis PJ, George S, Schultz DW, Rosner B, Klein ML (2007) Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration. JAMA 297(16):1793–1800

    Article  PubMed  CAS  Google Scholar 

  149. Despriet DD, Klaver CC, van Duijn CC, Janssens AC (2007) Predictive value of multiple genetic testing for age-related macular degeneration. Arch Ophthalmol 125(9):1270–1271

    Article  PubMed  Google Scholar 

  150. Wang G, Spencer KL, Scott WK et al (2010) Analysis of the indel at the ARMS2 3′UTR in age-related macular degeneration. Hum Genet 127(5):595–602

    Article  PubMed  CAS  Google Scholar 

  151. Yang Z, Tong Z, Chen Y et al (2010) Genetic and functional dissection of HTRA1 and LOC387715 in age-related macular degeneration. PLoS Genet 6(2):e1000836

    Article  PubMed  CAS  Google Scholar 

  152. Richardson AJ, Islam FA, Aung KZ, Guymer RH, Baird PN (2010) Analysis of the chromosome 10q26 region indicates the intergenic region between the tagSNP rs3793917 and rs11200638 in the HTRA1 gene as associated with age-related macular degeneration. Invest Ophthalmol Vis Sci 51(10):4932–4936

    Article  PubMed  Google Scholar 

  153. Ross RJ, Bojanowski CM, Wang JJ et al (2007) The LOC387715 polymorphism and age-related macular degeneration: replication in three case-control samples. Invest Ophthalmol Vis Sci 48(3):1128–1132

    Article  PubMed  Google Scholar 

  154. Lu F, Hu J, Zhao P et al (2007) HTRA1 variant increases risk to neovascular age-related macular degeneration in Chinese population. Vision Res 47(24):3120–3123

    Article  PubMed  CAS  Google Scholar 

  155. Gotoh N, Nakanishi H, Hayashi H et al (2009) ARMS2 (LOC387715) variants in Japanese patients with exudative age-related macular degeneration and polypoidal choroidal vasculopathy. Am J Ophthalmol 147(6):1037–1041, 1041 e1031-1032

    Article  PubMed  CAS  Google Scholar 

  156. Hadley D, Orlin A, Brown G et al (2010) Analysis of six genetic risk factors highly associated with AMD in the region surrounding ARMS2 and HTRA1 on chromosome 10, region q26. Invest Ophthalmol Vis Sci 51(4):2191–2196

    Article  PubMed  Google Scholar 

  157. Barron MJ, Johnson MA, Andrews RM et al (2001) Mitochondrial abnormalities in ageing macular photoreceptors. Invest Ophthalmol Vis Sci 42(12):3016–3022

    PubMed  CAS  Google Scholar 

  158. Feher J, Kovacs I, Artico M, Cavallotti C, Papale A, Balacco Gabrieli C (2006) Mitochondrial alterations of retinal pigment epithelium in age-related macular degeneration. Neurobiol Aging 27(7):983–993

    Article  PubMed  CAS  Google Scholar 

  159. Jarrett SG, Lin H, Godley BF, Boulton ME (2008) Mitochondrial DNA damage and its potential role in retinal degeneration. Prog Retin Eye Res 27(6):596–607

    Article  PubMed  CAS  Google Scholar 

  160. Liang FQ, Godley BF (2003) Oxidative stress-induced mitochondrial DNA damage in human retinal pigment epithelial cells: a possible mechanism for RPE aging and age-related macular degeneration. Exp Eye Res 76(4):397–403

    Article  PubMed  CAS  Google Scholar 

  161. Wang AL, Lukas TJ, Yuan M, Neufeld AH (2008) Increased mitochondrial DNA damage and down-regulation of DNA repair enzymes in aged rodent retinal pigment epithelium and choroid. Mol Vis 14:644–651

    PubMed  Google Scholar 

  162. Wang G, Spencer KL, Court BL et al (2009) Localization of age-related macular degeneration-associated ARMS2 in cytosol, not mitochondria. Invest Ophthalmol Vis Sci 50(7):3084–3090

    Article  PubMed  Google Scholar 

  163. Kortvely E, Hauck SM, Duetsch G et al (2010) ARMS2 is a constituent of the extracellular matrix providing a link between familial and sporadic age-related macular degenerations. Invest Ophthalmol Vis Sci 51(1):79–88

    Article  PubMed  Google Scholar 

  164. Tang NP, Zhou B, Wang B, Yu RB (2009) HTRA1 promoter polymorphism and risk of age-related macular degeneration: a meta-analysis. Ann Epidemiol 19(10):740–745

    Article  PubMed  Google Scholar 

  165. Chen W, Xu W, Tao Q et al (2009) Meta-analysis of the association of the HTRA1 polymorphisms with the risk of age-related macular degeneration. Exp Eye Res 89(3):292–300

    Article  PubMed  CAS  Google Scholar 

  166. Chan CC, Shen D, Zhou M et al (2007) Human HtrA1 in the archived eyes with age-related macular degeneration. Trans Am Ophthalmol Soc 105:92–97; discussion 97–98

    PubMed  Google Scholar 

  167. Tuo J, Ross RJ, Reed GF et al (2008) The HtrA1 promoter polymorphism, smoking, and age-related macular degeneration in multiple case-control samples. Ophthalmology 115(11):1891–1898

    Article  PubMed  Google Scholar 

  168. Chowers I, Meir T, Lederman M et al (2008) Sequence variants in HTRA1 and LOC387715/ARMS2 and phenotype and response to photodynamic therapy in neovascular age-related macular degeneration in populations from Israel. Mol Vis 14:2263–2271

    PubMed  CAS  Google Scholar 

  169. Zumbrunn J, Trueb B (1996) Primary structure of a putative serine protease specific for IGF-binding proteins. FEBS Lett 398(2–3):187–192

    Article  PubMed  CAS  Google Scholar 

  170. Oka C, Tsujimoto R, Kajikawa M et al (2004) HtrA1 serine protease inhibits signaling mediated by Tgfbeta family proteins. Development 131(5):1041–1053

    Article  PubMed  CAS  Google Scholar 

  171. Mathura JR Jr, Jafari N, Chang JT et al (2000) Bone morphogenetic proteins-2 and -4: negative growth regulators in adult retinal pigmented epithelium. Invest Ophthalmol Vis Sci 41(2):592–600

    PubMed  Google Scholar 

  172. Mahley RW (1988) Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240(4852):622–630

    Article  PubMed  CAS  Google Scholar 

  173. Ishida BY, Bailey KR, Duncan KG et al (2004) Regulated expression of apolipoprotein E by human retinal pigment epithelial cells. J Lipid Res 45(2):263–271

    Article  PubMed  CAS  Google Scholar 

  174. Slooter AJ, Tang MX, van Duijn CM et al (1997) Apolipoprotein E epsilon4 and the risk of dementia with stroke. A population-based investigation. JAMA 277(10):818–821

    Article  PubMed  CAS  Google Scholar 

  175. Evans DA, Beckett LA, Field TS et al (1997) Apolipoprotein E epsilon4 and incidence of Alzheimer disease in a community population of older persons. JAMA 277(10):822–824

    Article  PubMed  CAS  Google Scholar 

  176. Wang L, Clark ME, Crossman DK et al (2010) Abundant lipid and protein components of drusen. PLoS One 5(4):e10329

    Article  PubMed  CAS  Google Scholar 

  177. Anderson DH, Talaga KC, Rivest AJ, Barron E, Hageman GS, Johnson LV (2004) Characterization of beta amyloid assemblies in drusen: the deposits associated with aging and age-related macular degeneration. Exp Eye Res 78(2):243–256

    Article  PubMed  CAS  Google Scholar 

  178. Anderson DH, Ozaki S, Nealon M et al (2001) Local ­cellular sources of apolipoprotein E in the human retina and retinal pigmented epithelium: implications for the process of drusen formation. Am J Ophthalmol 131(6):767–781

    Article  PubMed  CAS  Google Scholar 

  179. Li CM, Clark ME, Chimento MF, Curcio CA (2006) Apolipoprotein localization in isolated drusen and retinal apolipoprotein gene expression. Invest Ophthalmol Vis Sci 47(7):3119–3128

    Article  PubMed  Google Scholar 

  180. Klaver CC, Kliffen M, van Duijn CM et al (1998) Genetic association of apolipoprotein E with age-related macular degeneration. Am J Hum Genet 63(1):200–206

    Article  PubMed  CAS  Google Scholar 

  181. Jarvik GP (1997) Genetic predictors of common disease: apolipoprotein E genotype as a paradigm. Ann Epidemiol 7(5):357–362

    Article  PubMed  CAS  Google Scholar 

  182. Zannis VI (1986) Genetic polymorphism in human apolipoprotein E. Methods Enzymol 128:823–851

    Article  PubMed  CAS  Google Scholar 

  183. Souied EH, Benlian P, Amouyel P et al (1998) The epsilon4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration. Am J Ophthalmol 125(3):353–359

    Article  PubMed  CAS  Google Scholar 

  184. Schmidt S, Klaver C, Saunders A et al (2002) A pooled case-control study of the apolipoprotein E (APOE) gene in age-related maculopathy. Ophthalmic Genet 23(4):209–223

    Article  PubMed  Google Scholar 

  185. Simonelli F, Margaglione M, Testa F et al (2001) Apolipoprotein E polymorphisms in age-related macular degeneration in an Italian population. Ophthalmic Res 33(6):325–328

    Article  PubMed  CAS  Google Scholar 

  186. Bojanowski CM, Shen D, Chew EY et al (2006) An apolipoprotein E variant may protect against age-related macular degeneration through cytokine regulation. Environ Mol Mutagen 47(8):594–602

    Article  PubMed  CAS  Google Scholar 

  187. Schmidt S, Saunders AM, De La Paz MA et al (2000) Association of the apolipoprotein E gene with age-related macular degeneration: possible effect modification by family history, age, and gender. Mol Vis 6:287–293

    PubMed  CAS  Google Scholar 

  188. Zareparsi S, Reddick AC, Branham KE et al (2004) Association of apolipoprotein E alleles with susceptibility to age-related macular degeneration in a large cohort from a single center. Invest Ophthalmol Vis Sci 45(5):1306–1310

    Article  PubMed  Google Scholar 

  189. Baird PN, Richardson AJ, Robman LD et al (2006) Apolipoprotein (APOE) gene is associated with progression of age-related macular degeneration (AMD). Hum Mutat 27(4):337–342

    Article  PubMed  CAS  Google Scholar 

  190. Pang CP, Baum L, Chan WM, Lau TC, Poon PM, Lam DS (2000) The apolipoprotein E epsilon4 allele is unlikely to be a major risk factor of age-related macular degeneration in Chinese. Ophthalmologica 214(4):289–291

    Article  PubMed  CAS  Google Scholar 

  191. Schultz DW, Klein ML, Humpert A et al (2003) Lack of an association of apolipoprotein E gene polymorphisms with familial age-related macular degeneration. Arch Ophthalmol 121(5):679–683

    Article  PubMed  CAS  Google Scholar 

  192. Utheim OA, Ritland JS, Utheim TP et al (2008) Apolipoprotein E genotype and risk for development of cataract and age-related macular degeneration. Acta Oph­thalmol 86(4):401–403

    Article  PubMed  Google Scholar 

  193. Wong TY, Shankar A, Klein R et al (2006) Apolipoprotein E gene and early age-related maculopathy: the Atheros­clerosis Risk in Communities Study. Ophthalmology 113(2):255–259

    Article  PubMed  Google Scholar 

  194. Gotoh N, Kuroiwa S, Kikuchi T et al (2004) Apolipoprotein E polymorphisms in Japanese patients with polypoidal choroidal vasculopathy and exudative age-related macular degeneration. Am J Ophthalmol 138(4):567–573

    Article  PubMed  CAS  Google Scholar 

  195. Baird PN, Guida E, Chu DT, Vu HT, Guymer RH (2004) The epsilon2 and epsilon4 alleles of the apolipoprotein gene are associated with age-related macular degeneration. Invest Ophthalmol Vis Sci 45(5):1311–1315

    Article  PubMed  Google Scholar 

  196. Tikellis G, Sun C, Gorin MB et al (2007) Apolipoprotein e gene and age-related maculopathy in older individuals: the cardiovascular health study. Arch Ophthalmol 125(1):68–73

    Article  PubMed  CAS  Google Scholar 

  197. Fritsche LG, Freitag-Wolf S, Bettecken T et al (2009) Age-related macular degeneration and functional promoter and coding variants of the apolipoprotein E gene. Hum Mutat 30(7):1048–1053

    Article  PubMed  CAS  Google Scholar 

  198. Beatty S, Koh H, Phil M, Henson D, Boulton M (2000) The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 45(2):115–134

    Article  PubMed  CAS  Google Scholar 

  199. Ma KL, Ruan XZ, Powis SH, Chen Y, Moorhead JF, Varghese Z (2008) Inflammatory stress exacerbates lipid accumulation in hepatic cells and fatty livers of apolipoprotein E knockout mice. Hepatology 48(3):770–781

    Article  PubMed  CAS  Google Scholar 

  200. Lynch JR, Wang H, Mace B et al (2005) A novel therapeutic derived from apolipoprotein E reduces brain inflammation and improves outcome after closed head injury. Exp Neurol 192(1):109–116

    Article  PubMed  CAS  Google Scholar 

  201. Mahley RW, Huang Y (2006) Apolipoprotein (apo) E4 and Alzheimer’s disease: unique conformational and biophysical properties of apoE4 can modulate neuropathology. Acta Neurol Scand Suppl 185:8–14

    Article  PubMed  CAS  Google Scholar 

  202. Lee SJ, Kim JH, Chung MJ et al (2007) Human apolipoprotein E2 transgenic mice show lipid accumulation in retinal pigment epithelium and altered expression of VEGF and bFGF in the eyes. J Microbiol Biotechnol 17(6):1024–1030

    PubMed  CAS  Google Scholar 

  203. Eiriksdottir G, Aspelund T, Bjarnadottir K et al (2006) Apolipoprotein E genotype and statins affect CRP levels through independent and different mechanisms: AGES-Reykjavik Study. Atherosclerosis 186(1):222–224

    Article  PubMed  CAS  Google Scholar 

  204. Austin MA, Zhang C, Humphries SE et al (2004) Heritability of C-reactive protein and association with apolipoprotein E genotypes in Japanese Americans. Ann Hum Genet 68(Pt 3):179–188

    Article  PubMed  CAS  Google Scholar 

  205. Judson R, Brain C, Dain B, Windemuth A, Ruano G, Reed C (2004) New and confirmatory evidence of an association between APOE genotype and baseline C-reactive protein in dyslipidemic individuals. Atherosclerosis 177(2):345–351

    Article  PubMed  CAS  Google Scholar 

  206. Manttari M, Manninen V, Palosuo T, Ehnholm C (2001) Apolipoprotein E polymorphism and C-reactive protein in dyslipidemic middle-aged men. Atherosclerosis 156(1):237–238

    Article  PubMed  CAS  Google Scholar 

  207. Marz W, Scharnagl H, Hoffmann MM, Boehm BO, Winkelmann BR (2004) The apolipoprotein E polymorphism is associated with circulating C-reactive protein (the Ludwigshafen risk and cardiovascular health study). Eur Heart J 25(23):2109–2119

    Article  PubMed  CAS  Google Scholar 

  208. Rontu R, Ojala P, Hervonen A et al (2006) Apolipoprotein E genotype is related to plasma levels of C-reactive protein and lipids and to longevity in nonagenarians. Clin Endocrinol (Oxf) 64(3):265–270

    Article  CAS  Google Scholar 

  209. Malek G, Johnson LV, Mace BE et al (2005) Apolipoprotein E allele-dependent pathogenesis: a model for age-related retinal degeneration. Proc Natl Acad Sci USA 102(33):11900–11905

    Article  PubMed  CAS  Google Scholar 

  210. Katsuya T, Baba S, Ishikawa K et al (2002) Epsilon 4 allele of apolipoprotein E gene associates with lower blood ­pressure in young Japanese subjects: the Suita Study. J Hypertens 20(10):2017–2021

    Article  PubMed  CAS  Google Scholar 

  211. Grindle CF, Marshall J (1978) Ageing changes in Bruch’s membrane and their functional implications. Trans Ophthalmol Soc U K 98(1):172–175

    PubMed  CAS  Google Scholar 

  212. Ignatius MJ, Gebicke-Harter PJ, Skene JH et al (1986) Expres­sion of apolipoprotein E during nerve degeneration and regeneration. Proc Natl Acad Sci USA 83(4):1125–1129

    Article  PubMed  CAS  Google Scholar 

  213. Poirier J, Baccichet A, Dea D, Gauthier S (1993) Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats. Neuro­science 55(1):81–90

    Article  PubMed  CAS  Google Scholar 

  214. De La Paz MA, Pericak-Vance MA, Lennon F, Haines JL, Seddon JM (1997) Exclusion of TIMP3 as a candidate locus in age-related macular degeneration. Invest Ophthalmol Vis Sci 38(6):1060–1065

    Google Scholar 

  215. Felbor U, Doepner D, Schneider U, Zrenner E, Weber BH (1997) Evaluation of the gene encoding the tissue inhibitor of metalloproteinases-3 in various maculopathies. Invest Ophthalmol Vis Sci 38(6):1054–1059

    PubMed  CAS  Google Scholar 

  216. Strunnikova NV, Maminishkis A, Barb JJ et al (2010) Transcriptome analysis and molecular signature of human retinal pigment epithelium. Hum Mol Genet 19(12):2468–2486

    Article  PubMed  CAS  Google Scholar 

  217. Weber BH, Vogt G, Pruett RC, Stohr H, Felbor U (1994) Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby’s fundus dystrophy. Nat Genet 8(4):352–356

    Article  PubMed  CAS  Google Scholar 

  218. Kathiresan S, Willer CJ, Peloso GM et al (2009) Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet 41(1):56–65

    Article  PubMed  CAS  Google Scholar 

  219. Willer CJ, Sanna S, Jackson AU et al (2008) Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet 40(2):161–169

    Article  PubMed  CAS  Google Scholar 

  220. Neale BM, Fagerness J, Reynolds R et al (2010) Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC). Proc Natl Acad Sci USA 107(16):7395–7400

    Article  PubMed  CAS  Google Scholar 

  221. Hasham SN, Pillarisetti S (2006) Vascular lipases, inflammation and atherosclerosis. Clin Chim Acta 372(1–2):179–183

    Article  PubMed  CAS  Google Scholar 

  222. Wang W, Connor SL, Johnson EJ, Klein ML, Hughes S, Connor WE (2007) Effect of dietary lutein and zeaxanthin on plasma carotenoids and their transport in lipoproteins in age-related macular degeneration. Am J Clin Nutr 85(3):762–769

    PubMed  CAS  Google Scholar 

  223. Tserentsoodol N, Gordiyenko NV, Pascual I, Lee JW, Fliesler SJ, Rodriguez IR (2006) Intraretinal lipid transport is dependent on high density lipoprotein-like particles and class B scavenger receptors. Mol Vis 12:1319–1333

    PubMed  CAS  Google Scholar 

  224. Curcio CA, Presley JB, Malek G, Medeiros NE, Avery DV, Kruth HS (2005) Esterified and unesterified cholesterol in drusen and basal deposits of eyes with age-related maculopathy. Exp Eye Res 81(6):731–741

    Article  PubMed  CAS  Google Scholar 

  225. Kindzelskii AL, Elner VM, Elner SG, Yang D, Hughes BA, Petty HR (2004) Toll-like receptor 4 (TLR4) of retinal pigment epithelial cells participates in transmembrane signaling in response to photoreceptor outer segments. J Gen Physiol 124(2):139–149

    Article  PubMed  CAS  Google Scholar 

  226. Elner SG, Petty HR, Elner VM et al (2005) TLR4 mediates human retinal pigment epithelial endotoxin binding and cytokine expression. Invest Ophthalmol Vis Sci 46(12):4627–4633

    Article  PubMed  Google Scholar 

  227. Lewin AS (2009) Geographic atrophy in age-related macular degeneration and TLR3. N Engl J Med 360(21):2251; author reply 2255–2256

    Article  PubMed  CAS  Google Scholar 

  228. Liew G, Mitchell P, Wong TY (2009) Geographic atrophy in age-related macular degeneration and TLR3. N Engl J Med 360(21):2252; author reply 2255–2256

    PubMed  CAS  Google Scholar 

  229. Allikmets R, Bergen AA, Dean M et al (2009) Geographic atrophy in age-related macular degeneration and TLR3. N Engl J Med 360(21):2252–2254; author reply 2255–2256

    PubMed  CAS  Google Scholar 

  230. Edwards AO, Chen D, Fridley BL et al (2008) Toll-like receptor polymorphisms and age-related macular degeneration. Invest Ophthalmol Vis Sci 49(4):1652–1659

    Article  PubMed  Google Scholar 

  231. Edwards AO, Swaroop A, Seddon JM (2009) Geographic atrophy in age-related macular degeneration and TLR3. N Engl J Med 360(21):2254–2255; author reply 2255–2256

    PubMed  CAS  Google Scholar 

  232. Cho Y, Wang JJ, Chew EY et al (2009) Toll-like receptor polymorphisms and age-related macular degeneration: replication in three case-control samples. Invest Ophthalmol Vis Sci 50(12):5614–5618

    Article  PubMed  Google Scholar 

  233. Despriet DD, Bergen AA, Merriam JE et al (2008) Comprehensive analysis of the candidate genes CCL2, CCR2, and TLR4 in age-related macular degeneration. Invest Ophthalmol Vis Sci 49(1):364–371

    Article  PubMed  Google Scholar 

  234. Kaur I, Hussain A, Hussain N et al (2006) Analysis of CFH, TLR4, and APOE polymorphism in India suggests the Tyr402His variant of CFH to be a global marker for age-related macular degeneration. Invest Ophthalmol Vis Sci 47(9):3729–3735

    Article  PubMed  Google Scholar 

  235. Richardson AJ, Islam FM, Guymer RH, Cain M, Baird PN (2007) A tag-single nucleotide polymorphisms approach to the vascular endothelial growth factor-A gene in age-related macular degeneration. Mol Vis 13:2148–2152

    PubMed  Google Scholar 

  236. Churchill AJ, Carter JG, Lovell HC et al (2006) VEGF polymorphisms are associated with neovascular age-related macular degeneration. Hum Mol Genet 15(19):2955–2961

    Article  PubMed  CAS  Google Scholar 

  237. Haines JL, Schnetz-Boutaud N, Schmidt S et al (2006) Functional candidate genes in age-related macular degeneration: significant association with VEGF, VLDLR, and LRP6. Invest Ophthalmol Vis Sci 47(1):329–335

    Article  PubMed  Google Scholar 

  238. Lin JM, Wan L, Tsai YY et al (2008) Vascular endothelial growth factor gene polymorphisms in age-related macular degeneration. Am J Ophthalmol 145(6):1045–1051

    Article  PubMed  CAS  Google Scholar 

  239. Boekhoorn SS, Isaacs A, Uitterlinden AG et al (2008) Polymorphisms in the vascular endothelial growth factor gene and risk of age-related macular degeneration: the Rotterdam Study. Ophthalmology 115(11):1899–1903

    Article  PubMed  Google Scholar 

  240. Kimura K, Isashiki Y, Sonoda S, Kakiuchi-Matsumoto T, Ohba N (2000) Genetic association of manganese superoxide dismutase with exudative age-related macular degeneration. Am J Ophthalmol 130(6):769–773

    Article  PubMed  CAS  Google Scholar 

  241. Kondo N, Bessho H, Honda S, Negi A (2009) SOD2 gene polymorphisms in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy. Mol Vis 15:1819–1826

    PubMed  CAS  Google Scholar 

  242. Gotoh N, Yamada R, Matsuda F, Yoshimura N, Iida T (2008) Manganese superoxide dismutase gene (SOD2) polymorphism and exudative age-related macular ­degeneration in the Japanese population. Am J Ophthalmol 146(1):146; author reply 146–147

    Article  PubMed  CAS  Google Scholar 

  243. Esfandiary H, Chakravarthy U, Patterson C, Young I, Hughes AE (2005) Association study of detoxification genes in age related macular degeneration. Br J Ophthalmol 89(4):470–474

    Article  PubMed  CAS  Google Scholar 

  244. Ikeda T, Obayashi H, Hasegawa G et al (2001) Paraoxonase gene polymorphisms and plasma oxidized low-density lipoprotein level as possible risk factors for exudative age-related macular degeneration. Am J Ophthalmol 132(2):191–195

    Article  PubMed  CAS  Google Scholar 

  245. Pauer GJ, Sturgill GM, Peachey NS, Hagstrom SA (2010) Protective effect of paraoxonase 1 gene variant Gln192Arg in age-related macular degeneration. Am J Ophthalmol 149(3):513–522

    Article  PubMed  CAS  Google Scholar 

  246. Baird PN, Chu D, Guida E, Vu HT, Guymer R (2004) Association of the M55L and Q192R paraoxonase gene polymorphisms with age-related macular degeneration. Am J Ophthalmol 138(4):665–666

    Article  PubMed  CAS  Google Scholar 

  247. Allikmets R (2000) Further evidence for an association of ABCR alleles with age-related macular degeneration. The International ABCR Screening Consortium. Am J Hum Genet 67(2):487–491

    Article  PubMed  CAS  Google Scholar 

  248. Allikmets R, Shroyer NF, Singh N et al (1997) Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration. Science 277(5333):1805–1807

    Article  PubMed  CAS  Google Scholar 

  249. Shroyer NF, Lewis RA, Yatsenko AN, Wensel TG, Lupski JR (2001) Cosegregation and functional analysis of mutant ABCR (ABCA4) alleles in families that manifest both Stargardt disease and age-related macular degeneration. Hum Mol Genet 10(23):2671–2678

    Article  PubMed  CAS  Google Scholar 

  250. Stone EM, Braun TA, Russell SR et al (2004) Missense variations in the fibulin 5 gene and age-related macular degeneration. N Engl J Med 351(4):346–353

    Article  PubMed  CAS  Google Scholar 

  251. Jones RP, Ridley C, Jowitt TA et al (2010) Structural effects of fibulin 5 missense mutations associated with age-related macular degeneration and cutis laxa. Invest Ophthalmol Vis Sci 51(5):2356–2362

    Article  PubMed  Google Scholar 

  252. Mullins RF, Olvera MA, Clark AF, Stone EM (2007) Fibulin-5 distribution in human eyes: relevance to age-related macular degeneration. Exp Eye Res 84(2):378–380

    Article  PubMed  CAS  Google Scholar 

  253. Lotery AJ, Baas D, Ridley C et al (2006) Reduced secretion of fibulin 5 in age-related macular degeneration and cutis laxa. Hum Mutat 27(6):568–574

    Article  PubMed  CAS  Google Scholar 

  254. Schultz DW, Weleber RG, Lawrence G et al (2005) HEMICENTIN-1 (FIBULIN-6) and the 1q31 AMD locus in the context of complex disease: review and perspective. Ophthalmic Genet 26(2):101–105

    Article  PubMed  CAS  Google Scholar 

  255. Schultz DW, Klein ML, Humpert AJ et al (2003) Analysis of the ARMD1 locus: evidence that a mutation in HEMICENTIN-1 is associated with age-related macular degeneration in a large family. Hum Mol Genet 12(24):3315–3323

    Article  PubMed  CAS  Google Scholar 

  256. Thompson CL, Klein BE, Klein R et al (2007) Complement factor H and hemicentin-1 in age-related macular degeneration and renal phenotypes. Hum Mol Genet 16(17):2135–2148

    Article  PubMed  CAS  Google Scholar 

  257. Hayashi M, Merriam JE, Klaver CC et al (2004) Evaluation of the ARMD1 locus on 1q25-31 in patients with age-related maculopathy: genetic variation in laminin genes and in exon 104 of HEMICENTIN-1. Ophthalmic Genet 25(2):111–119

    Article  PubMed  CAS  Google Scholar 

  258. Fisher SA, Rivera A, Fritsche LG et al (2007) Case-control genetic association study of fibulin-6 (FBLN6 or HMCN1) variants in age-related macular degeneration (AMD). Hum Mutat 28(4):406–413

    Article  PubMed  CAS  Google Scholar 

  259. Bojanowski CM, Tuo J, Chew EY, Csaky KG, Chan CC (2005) Analysis of Hemicentin-1, hOgg1, and E-selectin single nucleotide polymorphisms in age-related macular degeneration. Trans Am Ophthalmol Soc 103:37–44; discussion 44–35

    PubMed  Google Scholar 

  260. Ennis S, Jomary C, Mullins R et al (2008) Association between the SERPING1 gene and age-related macular degeneration: a two-stage case-control study. Lancet 372(9652):1828–1834

    Article  PubMed  CAS  Google Scholar 

  261. Allikmets R, Dean M, Hageman GS et al (2009) The SERPING1 gene and age-related macular degeneration. Lancet 374(9693):875–876; author reply 876–877

    Article  PubMed  Google Scholar 

  262. Park KH, Ryu E, Tosakulwong N, Wu Y, Edwards AO (2009) Common variation in the SERPING1 gene is not associated with age-related macular degeneration in two independent groups of subjects. Mol Vis 15:200–207

    PubMed  CAS  Google Scholar 

  263. Lu F, Zhao P, Fan Y et al (2010) An association study of SERPING1 gene and age-related macular degeneration in a Han Chinese population. Mol Vis 16:1–6

    PubMed  Google Scholar 

  264. Carter JG, Churchill AJ (2011) Analysis of SERPING1 and its association with age-related macular degeneration. Acta Ophthalmol 89(2):e212–e213

    Article  PubMed  Google Scholar 

  265. Thornton J, Edwards R, Mitchell P, Harrison RA, Buchan I, Kelly SP (2005) Smoking and age-related macular degeneration: a review of association. Eye (Lond) 19(9):935–944

    Article  CAS  Google Scholar 

  266. Neuner B, Komm A, Wellmann J et al (2009) Smoking history and the incidence of age-related macular degeneration–results from the Muenster Aging and Retina Study (MARS) cohort and systematic review and meta-analysis of observational longitudinal studies. Addict Behav 34(11):938–947

    Article  PubMed  Google Scholar 

  267. Tomany SC, Wang JJ, Van Leeuwen R et al (2004) Risk factors for incident age-related macular degeneration: pooled findings from 3 continents. Ophthalmology 111(7):1280–1287

    Article  PubMed  Google Scholar 

  268. Evans JR, Fletcher AE, Wormald RP (2005) 28,000 cases of age related macular degeneration causing visual loss in people aged 75 years and above in the United Kingdom may be attributable to smoking. Br J Ophthalmol 89(5):550–553

    Article  PubMed  CAS  Google Scholar 

  269. van Leeuwen R, Boekhoorn S, Vingerling JR et al (2005) Dietary intake of antioxidants and risk of age-related macular degeneration. JAMA 294(24):3101–3107

    Article  PubMed  Google Scholar 

  270. Tan JS, Wang JJ, Flood V, Rochtchina E, Smith W, Mitchell P (2008) Dietary antioxidants and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. Ophthalmology 115(2):334–341

    Article  PubMed  Google Scholar 

  271. VandenLangenberg GM, Mares-Perlman JA, Klein R, Klein BE, Brady WE, Palta M (1998) Associations between antioxidant and zinc intake and the 5-year incidence of early age-related maculopathy in the Beaver Dam Eye Study. Am J Epidemiol 148(2):204–214

    Article  PubMed  CAS  Google Scholar 

  272. SanGiovanni JP, Chew EY, Agron E et al (2008) The relationship of dietary omega-3 long-chain polyunsaturated fatty acid intake with incident age-related macular degeneration: AREDS report no. 23. Arch Ophthalmol 126(9):1274–1279

    Article  PubMed  Google Scholar 

  273. Chua B, Flood V, Rochtchina E, Wang JJ, Smith W, Mitchell P (2006) Dietary fatty acids and the 5-year incidence of age-related maculopathy. Arch Ophthalmol 124(7):981–986

    Article  PubMed  CAS  Google Scholar 

  274. Cho E, Hung S, Willett WC et al (2001) Prospective study of dietary fat and the risk of age-related macular degeneration. Am J Clin Nutr 73(2):209–218

    PubMed  CAS  Google Scholar 

  275. Chong EW, Kreis AJ, Wong TY, Simpson JA, Guymer RH (2008) Dietary omega-3 fatty acid and fish intake in the primary prevention of age-related macular degeneration: a systematic review and meta-analysis. Arch Ophthalmol 126(6):826–833

    Article  PubMed  Google Scholar 

  276. Fraser-Bell S, Wu J, Klein R et al (2008) Cardiovascular risk factors and age-related macular degeneration: the Los Angeles Latino Eye Study. Am J Ophthalmol 145(2):308–316

    Article  PubMed  Google Scholar 

  277. Smith W, Mitchell P, Leeder SR, Wang JJ (1998) Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: the Blue Mountains Eye Study. Arch Ophthalmol 116(5):583–587

    PubMed  CAS  Google Scholar 

  278. Klein BE, Klein R, Lee KE, Jensen SC (2001) Measures of obesity and age-related eye diseases. Ophthalmic Epidemiol 8(4):251–262

    Article  PubMed  CAS  Google Scholar 

  279. Delcourt C, Michel F, Colvez A, Lacroux A, Delage M, Vernet MH (2001) Associations of cardiovascular disease and its risk factors with age-related macular degeneration: the POLA study. Ophthalmic Epidemiol 8(4):237–249

    Article  PubMed  CAS  Google Scholar 

  280. Age-Related Eye Disease Study Research Group (2000) Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3. Ophthalmology 107(12):2224–2232

    Article  Google Scholar 

  281. Clemons TE, Milton RC, Klein R, Seddon JM, Ferris FL 3rd (2005) Risk factors for the incidence of advanced age-related macular degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19. Ophthalm­ology 112(4):533–539

    Article  PubMed  Google Scholar 

  282. Johnson EJ (2005) Obesity, lutein metabolism, and age-related macular degeneration: a web of connections. Nutr Rev 63(1):9–15

    Article  PubMed  Google Scholar 

  283. Seddon JM, Gensler G, Milton RC, Klein ML, Rifai N (2004) Association between C-reactive protein and age-related macular degeneration. JAMA 291(6):704–710

    Article  PubMed  CAS  Google Scholar 

  284. Klein R, Deng Y, Klein BE et al (2007) Cardiovascular disease, its risk factors and treatment, and age-related macular degeneration: women’s health initiative sight exam ancillary study. Am J Ophthalmol 143(3):473–483

    Article  PubMed  Google Scholar 

  285. Kornzweig AL (1977) Changes in the choriocapillaris associated with senile macular degeneration. Ann Ophth­almol 9(6):753–756, 759–762

    PubMed  CAS  Google Scholar 

  286. Pauleikhoff D, Chen JC, Chisholm IH, Bird AC (1990) Choroidal perfusion abnormality with age-related Bruch’s membrane change. Am J Ophthalmol 109(2):211–217

    PubMed  CAS  Google Scholar 

  287. Cackett P, Wong TY, Aung T et al (2008) Smoking, cardiovascular risk factors, and age-related macular degeneration in Asians: the Singapore Malay Eye Study. Am J Ophthalmol 146(6):960–967 e961

    Article  PubMed  Google Scholar 

  288. Kawasaki R, Wang JJ, Ji GJ et al (2008) Prevalence and risk factors for age-related macular degeneration in an adult Japanese population: the Funagata study. Ophthalm­ology 115(8):1376–1381, 1381 e1371–1372

    Article  PubMed  Google Scholar 

  289. Tan JS, Mitchell P, Smith W, Wang JJ (2007) Cardiovascular risk factors and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. Ophthalmology 114(6):1143–1150

    Article  PubMed  Google Scholar 

  290. Blumenkranz MS, Russell SR, Robey MG, Kott-Blumenkranz R, Penneys N (1986) Risk factors in age-related maculopathy complicated by choroidal neovascularization. Ophthalm­ology 93(5):552–558

    PubMed  CAS  Google Scholar 

  291. Hogg RE, Woodside JV, Gilchrist SE et al (2008) Cardiovascular disease and hypertension are strong risk factors for choroidal neovascularization. Ophthalmology 115(6):1046–1052 e1042

    Article  PubMed  Google Scholar 

  292. Klein R, Klein BE, Tomany SC, Cruickshanks KJ (2003) The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 110(6):1273–1280

    Article  PubMed  Google Scholar 

  293. van Leeuwen R, Ikram MK, Vingerling JR, Witteman JC, Hofman A, de Jong PT (2003) Blood pressure, atherosclerosis, and the incidence of age-related maculopathy: the Rotterdam Study. Invest Ophthalmol Vis Sci 44(9):3771–3777

    Article  PubMed  Google Scholar 

  294. Liu IY, White L, LaCroix AZ (1989) The association of age-related macular degeneration and lens opacities in the aged. Am J Public Health 79(6):765–769

    Article  PubMed  CAS  Google Scholar 

  295. Klein R, Klein BE, Wang Q, Moss SE (1994) Is age-related maculopathy associated with cataracts? Arch Ophthalmol 112(2):191–196

    Article  PubMed  CAS  Google Scholar 

  296. van der Schaft TL, Mooy CM, de Bruijn WC, Mulder PG, Pameyer JH, de Jong PT (1994) Increased prevalence of disciform macular degeneration after cataract extraction with implantation of an intraocular lens. Br J Ophthalmol 78(6):441–445

    Article  PubMed  Google Scholar 

  297. Armbrecht AM, Findlay C, Aspinall PA, Hill AR, Dhillon B (2003) Cataract surgery in patients with age-related macular degeneration: one-year outcomes. J Cataract Refract Surg 29(4):686–693

    Article  PubMed  Google Scholar 

  298. Blair CJ, Ferguson J Jr (1979) Exacerbation of senile macular degeneration following cataract extraction. Am J Ophthalmol 87(1):77–83

    PubMed  CAS  Google Scholar 

  299. Cugati S, Mitchell P, Rochtchina E, Tan AG, Smith W, Wang JJ (2006) Cataract surgery and the 10-year incidence of age-related maculopathy: the Blue Mountains Eye Study. Ophthalmology 113(11):2020–2025

    Article  PubMed  Google Scholar 

  300. Freeman EE, Munoz B, West SK, Tielsch JM, Schein OD (2003) Is there an association between cataract surgery and age-related macular degeneration? Data from three population-based studies. Am J Ophthalmol 135(6):849–856

    Article  PubMed  Google Scholar 

  301. Klein R, Klein BE, Wong TY, Tomany SC, Cruickshanks KJ (2002) The association of cataract and cataract surgery with the long-term incidence of age-related maculopathy: the Beaver Dam eye study. Arch Ophthalmol 120(11):1551–1558

    PubMed  Google Scholar 

  302. Pollack A, Marcovich A, Bukelman A, Oliver M (1996) Age-related macular degeneration after extracapsular cataract extraction with intraocular lens implantation. Ophthal­mology 103(10):1546–1554

    PubMed  CAS  Google Scholar 

  303. Sutter FK, Menghini M, Barthelmes D et al (2007) Is ­pseudophakia a risk factor for neovascular age-related macular degeneration? Invest Ophthalmol Vis Sci 48(4):1472–1475

    Article  PubMed  Google Scholar 

  304. Wang JJ, Klein R, Smith W, Klein BE, Tomany S, Mitchell P (2003) Cataract surgery and the 5-year incidence of late-stage age-related maculopathy: pooled findings from the Beaver Dam and Blue Mountains eye studies. Ophthal­mology 110(10):1960–1967

    Article  PubMed  Google Scholar 

  305. Wang JJ, Mitchell PG, Cumming RG, Lim R (1999) Cataract and age-related maculopathy: the Blue Mountains Eye Study. Ophthalmic Epidemiol 6(4):317–326

    Article  PubMed  CAS  Google Scholar 

  306. Ho L, Boekhoorn SS, Liana et al (2008) Cataract surgery and the risk of aging macula disorder: the Rotterdam study. Invest Ophthalmol Vis Sci 49(11):4795–4800

    Google Scholar 

  307. Chew EY, Sperduto RD, Milton RC et al (2009) Risk of advanced age-related macular degeneration after cataract surgery in the Age-Related Eye Disease Study: AREDS report 25. Ophthalmology 116(2):297–303

    Article  PubMed  Google Scholar 

  308. Scott WK, Schmidt S, Hauser MA et al (2007) Independent effects of complement factor H Y402H polymorphism and cigarette smoking on risk of age-related macular degeneration. Ophthalmology 114(6):1151–1156

    Article  PubMed  Google Scholar 

  309. Schaumberg DA, Hankinson SE, Guo Q, Rimm E, Hunter DJ (2007) A prospective study of 2 major age-related macular degeneration susceptibility alleles and interactions with modifiable risk factors. Arch Ophthalmol 125(1):55–62

    Article  PubMed  CAS  Google Scholar 

  310. Klein ML, Francis PJ, Rosner B et al (2008) CFH and LOC387715/ARMS2 genotypes and treatment with antioxidants and zinc for age-related macular degeneration. Ophthalmology 115(6):1019–1025

    Article  PubMed  Google Scholar 

  311. Wang JJ, Rochtchina E, Smith W et al (2009) Combined effects of complement factor H genotypes, fish consumption, and inflammatory markers on long-term risk for age-related macular degeneration in a cohort. Am J Epidemiol 169(5):633–641

    Article  PubMed  Google Scholar 

  312. Francis PJ, George S, Schultz DW et al (2007) The LOC387715 gene, smoking, body mass index, environmental associations with advanced age-related macular degeneration. Hum Hered 63(3–4):212–218

    PubMed  Google Scholar 

  313. Neuner B, Wellmann J, Dasch B et al (2008) LOC387715, smoking and their prognostic impact on visual functional status in age-related macular degeneration – The Muenster Aging and Retina Study (MARS) cohort. Ophthalmic Epidemiol 15(3):148–154

    Article  PubMed  Google Scholar 

  314. Lee SJ, Kim NR, Chin HS (2010) LOC387715/HTRA1 polymorphisms, smoking, and combined effects on exudative age-related macular degeneration in a Korean population. Clin Experiment Ophthalmol 38(7):698–704

    Article  PubMed  Google Scholar 

  315. Wang JJ, Ross RJ, Tuo J et al (2008) The LOC387715 polymorphism, inflammatory markers, smoking, and age-related macular degeneration. A population-based case-control study. Ophthalmology 115(4):693–699

    Article  PubMed  Google Scholar 

  316. Seitsonen SP, Onkamo P, Peng G et al (2008) Multifactor effects and evidence of potential interaction between complement factor H Y402H and LOC387715 A69S in age-related macular degeneration. PLoS One 3(12):e3833

    Article  PubMed  CAS  Google Scholar 

  317. Francis PJ, Zhang H, Dewan A, Hoh J, Klein ML (2008) Joint effects of polymorphisms in the HTRA1, LOC387715/ARMS2, and CFH genes on AMD in a Caucasian population. Mol Vis 14:1395–1400

    PubMed  CAS  Google Scholar 

  318. Kaur I, Katta S, Hussain A et al (2008) Variants in the 10q26 gene cluster (LOC387715 and HTRA1) exhibit enhanced risk of age-related macular degeneration along with CFH in Indian patients. Invest Ophthalmol Vis Sci 49(5):1771–1776

    Article  PubMed  Google Scholar 

  319. Cameron DJ, Yang Z, Gibbs D et al (2007) HTRA1 variant confers similar risks to geographic atrophy and neovascular age-related macular degeneration. Cell Cycle 6(9):1122–1125

    Article  PubMed  CAS  Google Scholar 

  320. Yoshida T, DeWan A, Zhang H et al (2007) HTRA1 promoter polymorphism predisposes Japanese to age-related macular degeneration. Mol Vis 13:545–548

    PubMed  CAS  Google Scholar 

  321. Schmidt S, Haines JL, Postel EA et al (2005) Joint effects of smoking history and APOE genotypes in age-related macular degeneration. Mol Vis 11:941–949

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology, and Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands

    L. Ho, J. R. Vingerling & C. C. W. Klaver

  2. Department of Ophthalmology, University Medical Center Utrecht, Utrecht, The Netherlands

    R. van Leeuwen

  3. Netherlands Institute for Neuroscience, Amsterdam, The Netherlands

    P. T. V. M. de Jong

Authors
  1. L. Ho
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. van Leeuwen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. T. V. M. de Jong
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. R. Vingerling
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. C. C. W. Klaver
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. C. W. Klaver .

Editor information

Editors and Affiliations

  1. Universitäts-Augenklinik Bonn, Universitätsklinikum Bonn, Ernst-Abbe-Str. 2, Bonn, 53127, Germany

    Frank G. Holz

  2. Zentrum für Refraktive Chirurgie, Hohenzollern-Klinik, Hohenzollernring 57, Münster, 48145, Germany

    Daniel Pauleikhoff

  3. Consultants of New York, Vitreous, Retina & Macula, Park Avenue 460, New York, 10022, New York, USA

    Richard F. Spaide

  4. , Deptartment of Ophthalmology, Moorfields Eye Hospital, City Road, London, EC1V 2PD, United Kingdom

    Alan C. Bird

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Ho, L., van Leeuwen, R., de Jong, P.T.V.M., Vingerling, J.R., Klaver, C.C.W. (2013). Epidemiology of AMD. In: Holz, F., Pauleikhoff, D., Spaide, R., Bird, A. (eds) Age-related Macular Degeneration. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-22107-1_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-22107-1_1

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-22106-4

  • Online ISBN: 978-3-642-22107-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation